Intellipharmaceutics International Inc. (IPCI)

[JJAAMMAANN]

When do we think an announcement will be made regarding the commercialization of Levetiracetam? I would have to believe that there were Pharma companies interested as soon as the ANDA was submitted to the FDA. With this and the paring of Rexista, this should really start to take off in a couple months!

We received final approval from the FDA in February 2016 of our ANDA for levetiracetam extended release tablets for the 500 mg and 750 mg strengths. Our newly approved product is the generic equivalent of the branded product Keppra XR ® sold in the United States by UCB, Inc. Keppra XR®, and the drug active levetiracetam, are indicated for use in the treatment of partial onset seizures associated with epilepsy. We are actively exploring the best approach to maximize the commercial returns from the new approval.